Email updates

Keep up to date with the latest news and content from AIDS Research and Therapy and BioMed Central.

Open Access Highly Accessed Case report

HIV post exposure prophylaxis induced bicytopenia: a case report

Benjamin T Schleenvoigt13*, John P Fobiwe1, Peter M Keller13, Stefan Hagel124 and Mathias W Pletz14

Author Affiliations

1 Center for Infectious Diseases and Infection Control, Jena University Hospital, Erlanger Allee 101, Jena, Thuringia 07740, Germany

2 Department of Internal Medicine IV, Jena University Hospital, Jena, Germany

3 Institute for Medical Microbiology, Jena University Hospital, Jena, Germany

4 Center for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany

For all author emails, please log on.

AIDS Research and Therapy 2014, 11:11  doi:10.1186/1742-6405-11-11

Published: 7 February 2014

Abstract

Long and short term side effects of antiretroviral drugs are not fully understood yet. Here a case of reversible blood count changes following post exposure prophylaxis with tenofovir/emtricitabin and lopinavir/ritonavir is reported. We propose that antiretroviral drugs used in post exposure prophylaxis may have a significant impact on hematopoiesis.

Keywords:
HIV; Post exposure prophylaxis; Leukopenia; Thrombocytopenia; Tenofovir; Emtricitabin; Lopinavir; Ritonavir